Allergan Doesn’t Oppose MDL For Biocell Breast Implants But Suggests New Jersey
(November 4, 2019, 1:45 PM EST) -- WASHINGTON, D.C. — Allergan Inc. on Nov. 1 told a federal judicial panel that it does not opposed centralization of 17 federal medical monitoring lawsuits involving Biocell textured breast implants but...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login